乳腺癌是全球最常见的癌症，死亡率很高。最近的研究提供了关于肠道微生物群在乳腺癌发病和进展中的作用的重要见解，证实了其对疾病治疗的影响。尽管有大量研究探索这种关系，但缺乏全面的文献计量分析来概述该领域的现状和新兴趋势。本研究旨在通过分析关键研究方向和识别新兴热点来填补这一空白。2013 年至 2023 年的出版物检索自 Web of Science 核心合集数据库。利用VOSviewer、R语言和SCImago Graphica软件对该领域的出版物数量、国家/地区、机构、作者和关键词进行分析和可视化。本研究共纳入515篇出版物。 《Cancers》杂志被认为是最多产的杂志，共贡献了 21 篇论文。美国和中国是这一领域的主要贡献者。阿拉巴马大学伯明翰分校是生产力最高的机构。 Peter Bai 发表论文最多，而 James J. Goedert 是被引用次数最多的作者。对高被引文献和关键词聚类的分析证实了肠道微生物群与乳腺癌之间的密切关系。关键词分析中“代谢组学”、“益生菌”等关键词被突出显示，表明探索乳腺癌微环境中代谢物与肠道菌群相互作用的未来研究热点。此外，这些关键词表明人们对益生菌治疗乳腺癌的潜力很感兴趣。肠道微生物群与乳腺癌之间关系的研究正在扩大。应重点了解它们相互作用的机制，特别是代谢物-微生物群-乳腺癌的相互作用。这些见解有可能推进乳腺癌的预防、诊断和治疗策略。这项文献计量研究对该领域的研究现状和未来趋势进行了全面评估，为未来肠道微生物群和乳腺癌的研究提供了宝贵的视角。版权所有 © 2024 Deng, Yang, Tian, Ling, Ruan, Ge, Liu and扇子。

Breast cancer is the most prevalent cancer globally and is associated with significant mortality. Recent research has provided crucial insights into the role of gut microbiota in the onset and progression of breast cancer, confirming its impact on the disease's management. Despite numerous studies exploring this relationship, there is a lack of comprehensive bibliometric analyses to outline the field's current state and emerging trends. This study aims to fill that gap by analyzing key research directions and identifying emerging hotspots.Publications from 2013 to 2023 were retrieved from the Web of Science Core Collection database. The VOSviewer, R language and SCImago Graphica software were utilized to analyze and visualize the volume of publications, countries/regions, institutions, authors, and keywords in this field.A total of 515 publications were included in this study. The journal Cancers was identified as the most prolific, contributing 21 papers. The United States and China were the leading contributors to this field. The University of Alabama at Birmingham was the most productive institution. Peter Bai published the most papers, while James J. Goedert was the most cited author. Analysis of highly cited literature and keyword clustering confirmed a close relationship between gut microbiota and breast cancer. Keywords such as "metabolomics" and "probiotics" have been prominently highlighted in the keyword analysis, indicating future research hotspots in exploring the interaction between metabolites in the breast cancer microenvironment and gut microbiota. Additionally, these keywords suggest significant interest in the therapeutic potential of probiotics for breast cancer treatment.Research on the relationship between gut microbiota and breast cancer is expanding. Attention should be focused on understanding the mechanisms of their interaction, particularly the metabolite-microbiota-breast cancer crosstalk. These insights have the potential to advance prevention, diagnosis, and treatment strategies for breast cancer. This bibliometric study provides a comprehensive assessment of the current state and future trends of research in this field, offering valuable perspectives for future studies on gut microbiota and breast cancer.Copyright © 2024 Deng, Yang, Tian, Ling, Ruan, Ge, Liu and Fan.